ERT Expands Suite of eCOA Offerings to Include Bring Your Own Device (BYOD) Solution
Philadelphia (PRWEB) June 16, 2014 -- ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced an expansion to its comprehensive suite of electronic Clinical Outcome Assessment (eCOA) data collection solutions for use in clinical trials. With this expansion, clinical trial sponsors can improve trial efficiencies while reliably collecting important eCOA data via patients’ personal Apple® (iOS) or Android™ phones and tablets.
An extension of ERT’s flagship DIARYpro® solution, the Bring Your Own Device (BYOD) option is based on over 25 years of scientifically and regulatory-proven COA data collection experience. This native mobile application enables trial sponsors to acquire high-quality eCOA data while eliminating the cost and time associated with purchasing, shipping, and managing a global fleet of dedicated eCOA devices. In addition, ERT’s BYOD solution ensures that assessments are presented consistently across different device types and screen resolutions.
“DIARYpro has set the industry standard for high data quality and reliability,” said Bob Young, Executive Vice President and Product Line Executive, eCOA at ERT. “In expanding the solution to include a BYOD option, we conducted significant research among global clinical trial sponsors to ensure it not only meets these standards, but also offers valuable features that will streamline the eCOA data collection process.”
Unlike other mobile applications that run within web browsers and require a live internet connection, ERT’s BYOD solution allows fully-offline operation for when data must be entered during strict time windows, regardless of internet connectivity. Further, on-device reminders to begin or continue assessments are not dependent on any external email or text server, and these notifications blend naturally into smartphone users’ daily lives, enhancing compliance.
Having supported over 1,200 COA global clinical trials to date, ERT’s solutions and services are routinely relied upon by biopharmaceutical researchers for capturing important patient data during clinical development. For more information on ERT’s comprehensive suite of eCOA data collection solutions, including BYOD, visit http://www.ert.com/eCOA.
About ERT
ERT (http://www.ert.com) is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services, and consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process throughout the product lifecycle. ERT delivers the most widely deployed solutions in centralized cardiac safety, respiratory services, suicide risk assessment and Clinical Outcome Assessments (COAs) – which includes patient, clinician, and observer reported outcomes. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes, and delivers safety and efficacy data critical to the approval, labeling, and reimbursement of pharmaceutical products. ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., U.K., Japan, and Germany.
Christine Tobin, ERT, http://www.ert.com/, +1 (412) 719-4568, [email protected]
Share this article